This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Alexandros Strikoudis
Introduction
Alexandros Strikoudis is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of eukaryotic cells that can produce adeno-associated viruses.
Latest Patents
Strikoudis holds a patent for "Eukaryotic cells comprising adenovirus-associated virus polynucleotides." This invention provides eukaryotic cells, such as mammalian cells, that include adeno-associated virus (AAV) polynucleotides, including AAV capsid proteins (Cap). These cells are capable of expressing the polypeptides encoded by the AAV polynucleotides, enabling the production of AAV, including recombinant AAV. The invention also encompasses methods for expressing AAV and adenovirus (Ad) polynucleotides in various eukaryotic cells, such as CHO cells, HEK 293, and BHK cells. Strikoudis has 1 patent to his name.
Career Highlights
Strikoudis is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to innovate in the field of genetic engineering and virology. His work has the potential to impact therapeutic approaches in medicine.
Collaborations
He has collaborated with notable colleagues, including Michael Goren and Yu Zhao, contributing to advancements in their shared field of expertise.
Conclusion
Alexandros Strikoudis is a prominent figure in biotechnology, with a focus on eukaryotic cell innovations. His work at Regeneron Pharmaceuticals and his patent contributions highlight his role in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile